Nitrosamine Impurities Testing With the Updated FDA Guidance

Nitrosamine impurities have recently become a very important topic in the world of pharmaceuticals. Ever since unacceptable levels of this probable carcinogen were detected in common drugs (including angiotension II receptor blockers, Zantac, metformin), regulatory authorities have recognized the need to reduce this risk and educate others on the matter. At the beginning of [...]

Nucro-Technics at the 2019 BIO International Convention

As with every year in June, twenty thousand attendees throughout the pharmaceutical and biotech industry converge on a city in the United States for the BIO Conference. These attendees cover more than 1,000 biotech companies, academic institutions, regional hubs, and related organizations throughout Canada, the United States, and across the world. Nucro-Technics has been [...]